REA Control Antibody (I), human IgG1, REAfinity™
Synonyms: keyhole limpet hemocyanin
RECOMBINANT
Bioz Star95/100 Bioz rating
207 Citations4 Images
Clone:
REA293 | IS5-21F5
Type of antibody:
Isotype control antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
ICFC, 3D-IF, IF, IHC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:

Related products for REA Control Antibody (I), human IgG1, REAfinity™

Intracellular flow cytometry applications
APC
APC-Vio 770
Biotin
FITC
PE
PE-Vio 615
PE-Vio 670
PE-Vio 770
PerCP-Vio 700
Vio B515
Vio R667
Vio R720
VioBlue
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-120-709
Protocols:
Follow the protocol used for the primary antibody.
Description:
EA.hy926 cells, overnight serum starved and stimulated with 150 nM Calyculin A for 30 minutes, were fixed and permeabilized using the Cell Signaling Buffer Set A. Cells were stained with REA Control (I) antibodies or with the corresponding Anti-p120 Catenin (pT916) antibodies (right peaks). In case of Vio® 515 and Vio® R720, Jurkat cells were fixed, permeabilized, and stained with REA Control (I) antibodies or with the corresponding Anti-Ki-67 antibodies (right peaks). Cells were analyzed by flow cytometry using the MACSQuant® Analyzer.Cell debris were excluded from the analysis based on scatter signals.

Application image
3D-Immunofluorescence applications
Vio 780
Vio B515
Vio G570
Vio R667
Tissue clearing:
MACS® Clearing Kit
Fixation:
PFA
Species tested:
human
Tissue used:
cerebral organoid
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
Vio 780
Used products:
130-135-516
Protocols:
Follow the protocol used for the primary antibody.
Description:
3D-immunofluorescence analysis of a human cerebral organoid fixed with 4% PFA and subjected to whole-mount immunostaining with REA Control Antibody (I), human IgG1, Vio® 780 (magenta). The samples were processed and optically cleared using the MACS® Clearing Kit and imaged with an UltraMicroscope Blaze light sheet instrument. Human cerebral organoid stained with REA Control Antibody (I), human IgG1, Vio 780 (A) and stained with Pax-6 Antibody, anti-human, Vio 780 (B). The image was processed using Denoise and Contrast Compression in MACS iQ View – 3D Large Volume Software. Scale bars: 300 µm (A, B).

A

Application imageView details view details

B

Application imageView details view details
Specifications for REA Control Antibody (I), human IgG1, REAfinity™
Overview

The REA Control (I) antibody clone REA293 is a universal isotype control that can be used with all recombinant engineered antibodies (REAfinity™ Antibodies) that recognize intracellular antigens. REAfinity Antibodies have been engineered for their high specificity and contain human IgG1 parts for constant regions. Unspecific interactions of the fluorochrome can be controlled for with conjugated versions of clone REA293. For intracellular stainings however the isotype control staining should be combined with other negative controls (e.g. staining of unstimulated cells).

Alternative names

keyhole limpet hemocyanin

Detailed product information

Technical specifications

Clone
REA293
Clonality
monoclonal
Isotype
recombinant human IgG1
Host
human cell line
Type of antibody
Isotype control antibodies, Recombinant antibodies
Species reactivity
any
Antigen
KLH
RRID
AB_2784400, AB_2661681, AB_2905374, AB_2661684, AB_2905375, AB_2889742, AB_2784399, AB_2921861, AB_2751490, AB_2928823, AB_2857433

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Product data and images for REA Control Antibody (I), human IgG1, REAfinity™
Figure 1

EA.hy926 cells, overnight serum starved and stimulated with 150 nM Calyculin A for 30 minutes, were fixed and permeabilized using the Cell Signaling Buffer Set A. Cells were stained with REA Control (I) antibodies or with the corresponding Anti-p120 Catenin (pT916) antibodies (right peaks). In case of Vio® 515 and Vio® R720, Jurkat cells were fixed, permeabilized, and stained with REA Control (I) antibodies or with the corresponding Anti-Ki-67 antibodies (right peaks). Cells were analyzed by flow cytometry using the MACSQuant® Analyzer.

Cell debris were excluded from the analysis based on scatter signals.

Resources for REA Control Antibody (I), human IgG1, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support